Tag: Hēlo thrombectomy system
Endovascular Engineering receives two US FDA 510(k) clearances for PE thrombectomy...
Endovascular Engineering (E2) has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for both the Hēlo thrombectomy system and...
Endovascular Engineering’s ENGULF pivotal trial completes patient enrolment
Endovascular Engineering (E2) has completed patient enrolment in the pivotal cohort of its ENGULF trial, involving the Hēlo pulmonary embolism (PE) thrombectomy system.
The investigational...